TherapeuticsMD, Inc. (TXMD)
NASDAQ: TXMD · Real-Time Price · USD
1.270
+0.080 (6.72%)
At close: Nov 6, 2025, 4:00 PM EST
1.230
-0.040 (-3.15%)
After-hours: Nov 6, 2025, 7:35 PM EST
TherapeuticsMD Analyst Ratings
Total Analysts
n/a
Consensus Rating
n/a
Price Target
n/a
Upside
n/a
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates $5 | Hold | Reiterates | $5 | +293.70% | Aug 17, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Initiates $5 | Hold | Initiates | $5 | +293.70% | Jan 11, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates $1 | Hold | Reiterates | $1 | -21.26% | Jul 13, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $10 | Strong Buy → Hold | Downgrades | $10 | +687.40% | Jun 7, 2022 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy → Hold Downgrades $250 → $50 | Buy → Hold | Downgrades | $250 → $50 | +3,837.01% | May 6, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $150 → $125 | Strong Buy | Maintains | $150 → $125 | +9,742.52% | Mar 11, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $200 → $150 | Strong Buy | Maintains | $200 → $150 | +11,711.02% | Nov 12, 2021 |
| Jefferies | Jefferies | Hold → Sell Downgrades $63 → $60 | Hold → Sell | Downgrades | $63 → $60 | +4,624.41% | Aug 7, 2020 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | May 19, 2020 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $300 → $250 | Strong Buy | Reiterates | $300 → $250 | +19,585.04% | May 7, 2020 |
| Stifel | Stifel | Strong Buy Maintains $700 → $750 | Strong Buy | Maintains | $700 → $750 | +58,955.12% | Apr 16, 2020 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $350 → $300 | Strong Buy | Maintains | $350 → $300 | +23,522.05% | Feb 21, 2020 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $1,300 → $1,350 | Buy | Maintains | $1,300 → $1,350 | +106,199.21% | Aug 14, 2018 |
| JP Morgan | JP Morgan | Buy Initiates $550 | Buy | Initiates | $550 | +43,207.09% | Jun 15, 2018 |
| Deutsche Bank | Deutsche Bank | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +687.40% | Jul 21, 2017 |
| Oppenheimer | Oppenheimer | Hold → Buy Upgrades n/a | Hold → Buy | Upgrades | n/a | n/a | Jul 11, 2017 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.